AdventHealth has partnered with Biofourmis to introduce the AdventHealth Hospital at Home programme, which offers inpatient-level care to patients within their own homes. This innovative initiative utilises Biofourmis’ enterprise platform, which integrates continuous monitoring, US Food and Drugs Administration-cleared AI algorithms and remote clinical care teams to deliver personalised and comprehensive care. The programme's initial implementation will take place at AdventHealth Winter Park, with plans for future expansion to support AdventHealth’s broader care-at-home strategy. According to GlobalData, a leading data and analytics company, the initiative aims to provide a seamless patient experience, bridging the gap between hospital and post-acute care settings.
According to GlobalData forecasts, the remote patient monitoring market will reach sales of $760 million by 2030, up from $548.9 million in 2020 at a compound annual growth rate of 3.3%. The Biofourmis platform integrates AdventHealth’s Epic electronic health record (EHR) system to ensure seamless access to critical patient data, enabling clinicians to efficiently manage acute care at home. It also features advanced safety measures, including continuous monitoring, arrhythmia and fall detection, and a personal emergency response system, ensuring patient safety.
As healthcare systems increasingly adopt advanced technologies, partnerships such as the one between AdventHealth and Biofourmis demonstrate how innovation can result in better patient outcomes and operational efficiencies, as well as an enhanced healthcare experience.
